Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates

Company Performance - Sight Sciences, Inc. reported a quarterly loss of $0.28 per share, which was better than the Zacks Consensus Estimate of a loss of $0.29, and an improvement from a loss of $0.33 per share a year ago, indicating an earnings surprise of 3.45% [1] - The company posted revenues of $17.51 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 5.95%, although this represents a decline from year-ago revenues of $19.27 million [2] - Over the last four quarters, Sight Sciences has exceeded consensus EPS estimates three times and has topped consensus revenue estimates three times as well [2] Stock Performance - Sight Sciences shares have declined approximately 21.4% since the beginning of the year, contrasting with the S&P 500's decline of 4.3% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.30 on revenues of $18.38 million, and for the current fiscal year, it is -$1.15 on revenues of $72.02 million [7] Industry Outlook - The Medical - Instruments industry, to which Sight Sciences belongs, is currently ranked in the top 28% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]